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Human chorionic gonadotropin (hCG), a 37 kDa glycoprotein hormone, is a key diagnostic 
marker of pregnancy and has been cited as an important biomarker in relation to cancerous 
tumors found in the prostate, ovaries and bladder. 
A novel chemically-modified epitaxial graphene diagnostic sensor has been developed for 
ultrasensitive detection of the biomarker hCG. Multi-layer epitaxial graphene (MEG), grown 
on silicon carbide substrates, was patterned using electron beam lithography to produce 
channel based devices. The MEG channels have been amine terminated using 3-
Aminopropyl-triethoxysilane (APTES) in order to attach the anti-hCG antibody to the 
channel. 
Detection of binding of hCG with its graphene-bound antibody was monitored by measuring 
reduction of the channel current of the graphene biosensor. The sensitivity of the sensor 
device was investigated using varying concentrations of hCG, with changes in the channel 
resistance of the sensor observed upon exposure to hCG. The detection limit of the sensor was 
0.62 ng/mL and the sensor showed a linear response to hCG in the range 0.62 to 5.62 ng/mL 






















1. Introduction  
Electrochemical immunosensors offer a number of significant advantages, including high 
sensitivity, fast response, simplicity, and relatively low cost [1, 2] when compared with other 
types of immunosensor. These advantages make them attractive for high performance 
analytical detection of biomolecules [3]. Immunosensors capable of detecting nucleic acids 
[4], viruses [5], antigens [6], and hormone [7] biomarkers, based on silicon nanowire [5], 
carbon nanotube (CNT) [8], graphite [9] have been widely reported. Since the pioneering 
work on SiNW sensors by Lieber et al [10], SiNW sensors have been developed that are 
capable of detection limits down to fg ml-1 concentrations – such as reported for prostate 
specific antigen (PSA) detection by Kim et al [11]. CNT sensors have also been used to 
achieve detection of antigens e.g. PSA at ng ml-1 [8, 12]  
More recently, graphene has been utilized in a number of forms for sensor and biosensor 
applications [13-17]. 
Graphene’s electronic structure and high surface to volume ratio contribute to the high 
sensitivity of graphene sensor devices [18]. Various forms of graphene and related materials 
(such as exfoliated graphene [19], graphene oxide and epitaxial graphene [20]), have been 
reported for use in graphene-modified electrodes and graphene-composite electrodes. An 
electrochemical sensor, using chemically modified exfoliated graphene to detect dopamine 
(DA), was reported to have a detection limit of 0.01 µM. [21]. Li et al. reported a novel 
electrochemical immunosensor of the breast cancer marker protein CA 15-3 using a highly 
conductive graphene-modified electrode. This sensor was capable of sensitive and label-free 
detection with a detection limit of 0.012 IU/mL [19]. Yasuhide et al. reported a label-free 
immunosensor based on an aptamer-modified graphene field-effect transistor (G-FET).The 
aptamer-modified G-FET showed selective electrical detection of IgE protein with an 
dissociation constant of 47 nM, indicating good affinity and the potential for G-FETs to be 
used in biological sensors [15]. Srivastave et al. reported an easy method for producing 
functionalized multilayer graphene from multiwalled carbon nanotubes (MWCNTs) in mass 
scale using only concentrated H2SO4/HNO3. This biosensor shows linearity of 10-100 mg dL-
1, sensitivity of 5.43 μA mg-1 dL cm-2, lower detection limit of 3.9 mg dL-1, [22]. Lu et al. 
reported an hydrogen peroxide biosensor formed from single-layer graphene with a detection 
limit of 1.05x10-7 M [23]. Schedin et al. reported a sensor for detection of individual gas 
molecules adsorbed on graphene with a detection limit of 1 ppb [24]. 
Epitaxial growth on silicon carbide (SiC) is a widely used method of producing high quality 
graphene. Using insulating or semi-insulating SiC substrates enables the lithographic 
fabrication of graphene devices, for electronic applications without the need for transfer to 
other substrates [25, 26]. Graphene can be grown on both the silicon and carbon faces of 4H-
SiC, but growth is substantially different on each face, in terms of the morphology and 
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electronic structure of the resulting graphene layers [27]. Silicon face growth yields an 
interfacial layer between the SiC substrate and graphene, and typically grows layer-by-layer 
[28]. In contrast, carbon face growth yields layers which are decoupled from the SiC 
substrate, without a noticeable interface effect [29]. Larger growth domains are produced on 
the carbon face, which contributes to higher carrier mobilities in a microchannel device [30]. 
Graphene biosensors can be fabricated by covalent immobilization, of proteins to graphene 
surfaces [31, 32]. Covalent immobilization of antibody molecules onto graphene requires a 
chemical reaction of the COOH functional groups of the antibody, with amine groups, bound 
to the graphene surface, producing a peptide bond. Methods for amine functionalization of 
graphene include diazotization [33], thiol chemistry [34] and surface silanization using 
APTES. APTES attachment can be performed on various substrates provided they contain 
surface hydroxyl groups, which can react with alkoxysilanes to form covalent Si-O-C bonds 
to the underlying substrate.  
An epitaxial graphene immunosensor, capable of selectively detecting hCG, has been 
developed. Human chorionic gonadotropin (hCG) is a glycoprotein hormone composed of 
244 amino acids with a molecular mass of 36.7 kDa, produced by normal trophoblast cells of 
the placenta during pregnancy [35]. Trophoblast cells form the outer layer of a blastocyst, 
which provide nutrients to the embryo and develop into a large part of the placenta. 
Trophoblasts are formed during the first stage of pregnancy and are the first cells to 
differentiate from the fertilized egg. hCG is also produced by trophoblast cells in 
hydatidiform moles and choriocarcinoma (trophoblast diseases) in patients with germ cell 
tumors (testicular choriocarcinoma, placental site tumors and germ cell carcinomas of the 
ovary) and sometimes in patients with other malignancies [35].  
In this work, standard lithographic techniques have been used to pattern epitaxial graphene 
devices, whose dimensions are scalable and suitable for wafer scale production. Epitaxial 
graphene devices have been functionalized using APTES, the first reported use of APTES on 
epitaxial graphene devices, to achieve an amine-terminated graphene surface. Antibodies 
targeted against hCG have been bound to the amine-terminated graphene in the first reported 
amperometric immunosensor based on epitaxial graphene. Device fabrication and surface 
functionalisation methods are readily adaptable to other antibody/antigen systems, and are 
thus suitable as a generic immunosensor platform. 
 
2. Experimental Section 
2.1. Materials and Reagents 
Semi-insulating 4H-SiC substrates (nominally on-axis) were purchased from CREE. 
Synthetic urine was prepared with urea, sodium chloride, potassium chloride and sodium 
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phosphate purchased from Sigma-Aldrich. N-Hydroxysuccinimide (NHS) and N-(3-
Dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDAC), Di-tert-butyl 
dicarbonate (t-BOC), sodium bicarbonate, bovine serum albumin (BSA), phosphate buffered 
saline (PBS), Potassium hexacyanoferrate III (K3[Fe(CN)6]), potassium hexacyanoferrate II 
(K4[Fe(CN)6]) trihydrate, and trifluoroacetic acid were all purchased from Sigma-Aldrich. 
Electrochemical measurements of the surface modification were performed using an aqueous 
reference electrode (Ag/AgCl) purchased from IJ Cambria Scientific Ltd and platinum (Pt) 
auxiliary electrode from BASi. hCG protein was purchased from Abcam (UK). Anti-hCG 
antibody was supplied by Ig Innovations.  
 
2.2. Apparatus 
Graphene growth was performed in a Jipelec Rapid Thermal Processing SiC furnace fitted 
with a turbo molecular pump. An e-Line (Raith GmBH) electron beam lithography system 
was used to define the graphene channels and contacts of the sensor device. Plasma etching of 
the graphene device was performed in an Oxford Instruments PlasmaLab. Cyclic voltammetry 
measurements were performed using an EmStat2 Palm Sens potentiostat with the graphene 
channel device as the working electrode, a Pt auxillary electrode and Ag/AgCl reference 
electrode. Electrical measurements were performed using a Semi Probe LA-150 probe station 
with a Keithley 2602A Source Meter. Micro-Raman measurements were performed using a 
Renishaw InVia system with a 100 mW 532 nm excitation laser with approximately 10 mW 
of power on the sample. X-ray photoelectron spectroscopy (XPS) measurements were 
performed in a VG ESCAlab MKII with an Al X-ray excitation source (Kα of 1486 eV). 
 
2.3. Graphene growth and device fabrication 
4H-SiC wafers were cut into 10x10 mm samples and cleaned using a standard RCA 
procedure. Samples were etched in HF immediately prior to furnace growth to remove the 
native oxide. Multilayer graphene (MLG) was grown on the C-face of 4H-SiC at 1650°C and 
a vacuum of 10-4 mbar.  
Electron beam lithography (EBL) followed by oxygen plasma etching (50 sccm O2, 75 mTorr 
and 50 W RF power, 60 seconds) was used to pattern graphene channel devices. A second 
EBL exposure was used to define the sputtered Ti/Au metal contacts to the graphene device. 
A third EBL exposure was used to define a window in PMMA, thus exposing only the 
graphene channel and protecting the metal contacts and the SiC surface from any chemical 




2.4. Hydroxylation of surface  
The surface of the graphene channel devices was modified using the Fenton reaction [36], 
yielding an –OH terminated graphene layer. Epitaxial graphene samples were immersed in a 
solution of hydrogen peroxide and iron (II) sulfate, maintained at pH 3 for 30 minutes. Since 
the reaction is strongly exothermic, the iron sulfate powder was added to the solution 
incrementally and allowed to settle before introducing the graphene sample.  
Contact angle measurements taken before and after the –OH termination reaction showed that 
the graphene surface changed from hydrophobic (90°) to hydrophilic (26°) following –OH 
termination. 
 
2.5. Electrochemical assays 
Cyclic Voltammetry (CV) measurements were conducted in 5.0 mmol/L of [Fe(CN)6]3- and 
5.0 mmol/L of [Fe(CN)6]4-, prepared in PBS buffer, pH 7.4. For CV assays, the potential was 
scanned from -0.7 V to +0.7 V, at 50 mV/s. All assays were conducted in triplicate. 
 
2.6. Antibody immobilization with APTES  
The –OH terminated graphene surfaces were reacted in a solution of 40% (3-Aminopropyl) 
triethoxysilane (APTES) in ethanol for 1.5 hours, to obtain an amine-terminated surface 
(Figure 1). Amine groups of the anti-hCG antibody were protected using Di-tert-butyl 
dicarbonate (t-BOC) to prevent cross-linking and aggregation of antibodies. This also ensures 
that only the amine-terminated surface of the graphene channel binds to the carboxylic group 
of the antibody. 
The carboxylic groups of the antibody were activated using 50 mmol/L of N-(3-
Dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDAC), and 25 mmol/L of N-
hydrosucchimide (NHS). The EDAC generates an ester derivative of the antibody, which is 
subsequently stabilized by NHS in order to prevent it from undergoing hydrolysis and 
reverting back to the carboxylic acid. The ester derivative of anti-hCG subsequently reacts 
with the amine-terminated graphene surface, forming a peptide bond. The amine terminated 
graphene surface was exposed to a solution containing the activated antibodies for 2 hours at 
room temperature. 
 




Removal of the t-BOC protecting groups, restoring the NH2 groups on the antibody was 
achieved via cleavage of the amide bond between the t-BOC and the antibody using 
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trifluoroacetic acid (TFA) for 1 hour. This also hydrolyses the ester, generated by the 
activation of the carboxylic groups by EDAC and NHS, back into carboxylic groups. Bovine 
serum albumin (5% BSA in PBS) solution was subsequently applied for 10 minutes to the 
surface to block non-specific binding of the target hCG molecule to any free surface-amine 
groups.  
 
2.7. hCG binding 
hCG suspended in synthetic urine was applied at increasing concentrations, ranging from 3.1 
mIU/mL to 28 mIU/mL (0.62 ng/mL to 5.62 ng/mL) to the graphene channel. Each 
concentration was applied to the surface for 15 minutes, followed by washing in PBS and 
drying in nitrogen. 
 
3. Results and discussion 
3.1. Characterization of graphene devices 
The thickness of the graphene overlayer was estimated by curve fitting the C1s core level peak 
from the XPS spectra of graphene grown on SiC, and differentiating the components of this 
peak related to the SiC substrate and the graphene layer respectively (Figure 2, c). Assuming 
the graphene growth follows a Franck van der Merwe growth or layer-by-layer mode, [37] the 
intensity of the SiC buried layer would decay exponentially with the increase in thickness of 
the graphene overlayer. This follows the propagation probability of the electrons through the 
solid [38], with the mean free path calculated as being 1.39 nm [39]; thus the graphene 
overlayer was estimated as being 3 layers thick.  
Raman measurements on graphene channels, performed after lithographic fabrication steps, 
did not demonstrate any shifts due to contamination or damage to the graphene substrate. The 
position of the G peak in the Raman spectrum (1583 cm-1), as well as the attenuation of the 
SiC substrate [40] were both used to determine the number of graphene layers, which was 
found to be in agreement with XPS results. The SiC background was subtracted from all 
Raman spectra to provide a clear comparison of the graphene peaks. 
 
3.2. Characterization of surface modification 
XPS was used to confirm the attachment of the aminosilane on the surface via the analysis of 
Si2p, C1s and N1s peaks. Scans were performed with a pass energy of 10 eV. Curve fitting of 
the C1s and Si2p peaks was performed with a G/L ratio of 30%. The energy separation between 
the C1s peak attributed to the SiC and the C1s peak attributed to the graphene was kept 
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constant between the two experiments (before and after exposure to APTES), along with the 
FWHM of each peak.  
Following APTES functionalization, the appearance of a nitrogen peak at 398.9 eV, 
consistent with an amine group, and of a secondary Si2p peak at 101.4 eV (Figure 2, a and b), 
not present before functionalization, was observed. Taking into account the sensitivity factor 
of the different core levels, the contribution of both the nitrogen peak and the secondary 
silicon peak was found to be similar (Table 1), which is consistent with the 1:1 stoichiometric 
composition of the aminosilane. In addition, all the peaks shift by -0.1 eV, illustrating a Fermi 
shift, ergo a modification of the surface properties. 
Curve fitting of the C1s peak after exposure to APTES showed the appearance of a third C1s 
peak (in addition to the bulk SiC and graphene C1s peaks) attributed to the aliphatic carbon 
atoms of the APTES molecule (Figure 2, d). The contribution of these aliphatic carbon atoms 
to the XPS spectrum is just over 7 times that from the nitrogen or the silicon atoms of the 
APTES molecule. This is consistent with the stoichiometry expected when the APTES 
molecule (which should contain 9 carbon atoms) is bound to the graphene surface, after 
having lost an ethanol group, during the reaction with the hydroxyl-terminated surface. It was 
also observed that the intensity of the graphene peak decreased slightly, suggesting a 
modification of some of the sp2 carbon atoms in the top most graphene layer to sp3 hybridized 
carbon, due to the functionalization with hydroxyl groups. 
 
-Please insert figure 2 here- 
 
-Please insert Table1 here- 
 
Chemical modification of graphene channels (the working electrode) can be measured by 
monitoring the changes in the electron transfer properties of the redox system [Fe(CN)6]3- / 
[Fe(CN)6]4- using cyclic voltammetry (CV). These studies are based on the assumption that 
the [Fe(CN)6]3–/4– redox reaction is a simple, reversible electron transfer reaction. The 
ferri/ferrocyanide couple provides an ideal electrochemical probe for the study of chemically 
modified surfaces, since its reduction and oxidation both proceed via simple one electron 
transfer redox processes [41]. 
The obtained CV results from the hydroxyl-terminated graphene electrode before (control) 
and after modification with APTES are presented in Figure 3. The redox peak current of the 
control sample, corresponding to the oxidation potential of Fe(II), was at 464 mA. The peak 
current reduced to 110 mA for the APTES modified sample. This 354 mA shift of the redox 
peak indicates successful chemical modification of the surface with APTES as the formation 
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of the C-O-Si bond, between the graphene electrode and the APTES molecule, impedes the 
transfer of electrons between the electrode surface and the [Fe(CN)6]3–/4– electrolyte. 
 
-Please insert figure 3 here- 
 
Raman measurements were performed to monitor the effect of hydroxylation and APTES 
functionalization on the Raman spectrum of graphene (Figure 4). A notable increase in the D 
band intensity at ~1350 cm-1 was measured, with the ratio of the D (sp3 bonded C) to G (sp2 
bonded C) Raman peaks, I(D)/I(G), increasing from ~0.08 to ~0.8 after –OH and APTES 
modification. This can be understood as an increase in sp3 hybridized carbon in the graphene 
layer, resulting from the functionalization reaction. This has been previously reported by [42], 
for the modification of exfoliated graphene with diazonium salts.  
Raman mapping measurements were performed to assess any inhomogeneities in the APTES 
attachment. These mapping measurements of I(D)/I(G) indicated that APTES attached 
preferentially at the edges of the graphene channel, which may be caused by preferential 
hydroxylation of edge and defect sites during the Fenton reaction. 
 
-Please insert figure 4 here- 
 
 
3.3. Analytical performance of the sensor  
Current-voltage characterisation of the graphene channel device was performed after each 
step of the surface modification process; from pristine graphene to anti-hCG attachment, to 
application of hCG. The initial APTES attachment showed an increase by a factor of 4 in the 
channel resistivity, which is to be expected considering that the covalent attachment to the 
surface induces a large amount of lattice defects (sp3 sites) into the graphene lattice, as 
evidenced by the Raman spectra in (Figure 4). These defect sites enhance the scattering of 
charge carriers, thus reducing carrier mobility [43]. 
Zeta potential measurements performed on the antibody in PBS solution at pH 7.4 yielded a 
potential of -6.14 mV.  
Epitaxial graphene samples have been characterized as both n-type or p-type by different 
groups – depending on the growth conditions used [44]. In addition, the chemical 
functionalization of graphene may also influence the carrier type in graphene. The attachment 
of the negatively charged antibody is equivalent to a negative potential gating of the graphene 
channel, which if the graphene is n-type, would reduce the carrier density and thus the 
conductivity in the device. Analogous sensing mechanisms have been outlined in [45] for the 
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detection of negatively charged bacterial attachment to a p-type graphene-amine surface, 
whereby the hole current was increased by the negative gating potential.  
This mechanism is therefore similar to that of a graphene chemFET. Defective graphene, and 
graphene influenced by extrinsic defects from the substrate is reported to be particularly 
sensitive to this potential gating effect [46], whereas pristine (defect-free) graphene is not 
strongly sensitive to this sensing mechanism. The presence of defects in graphene causes the 
current modulation from chemical gating to be enhanced, translating into superior sensitivity 
in chemFETS. Graphene grown on the C face of SiC is not a flat, uniform layer, but instead 
commonly grows into step-bunched terraces [47]. It is likely that structural defects from the 
epitaxial graphene growth, and chemical defects from the hydroxylation (Fenton) step, both 
contribute to the sensitivity of the current modulation from binding of the antibody.  
Exposure of the antibody functionalized graphene sensor to the hCG antigen acts to increase 
the resistance across the channel. Indeed, increasing the concentration of hCG result in further 
increases in the graphene channel resistance, indicating that hCG was bound to the sensor. 
After exposure to concentrations above 5.62 ng/mL, the sensor response saturated, indicating 
that the active receptor sites had been occupied by the bound antigens. 
As the SiC substrate is semi-insulating, applying a back gate is not feasible using these 
samples. I-Vg measurements would be possible with a top or lateral gate, but this is beyond 
the scope of this work. 
 
3.4. Sensitivity, selectivity and linearity of the sensor 
Analysis of the biosensor response to hCG was carried out using varying concentrations of 
hCG in synthetic urine at pH 6.8. The sensor device (Figure 5), showed detectable changes in 
channel resistance upon exposure to hCG. The sensor had a linear response of 142 Ω/ng/mL 
over the concentration range (0.62 to 5.62 ng/mL) with a limit of detection (LOD) of 0.62 
ng/mL (3.1 mIU/mL). This range was chosen because the normal urinary concentration range 
of hCG in pregnant women is 5 mIU/mL to 117000 mIU/mL in clinical samples [48]). The 
graphene biosensor is thus more than sufficiently sensitive to detect the lower limit of hCG in 
clinical samples. For comparison, Manlan Tao et al. reported an hCG immunosensor with a 
LOD of 12 mIU/mL, which is linear in the range 25 to 400 mIU/mL [49].  
Optimization of the sensor or use of multiple sensors would be required in order to span the 
relevant clinical concentration range. This can be achieved by varying the device geometry. 
Synthetic urine, with no hCG analyte induced a small amperometric change in the device, 
probably due to the electrolytic gating effect. 
The unmodified graphene device had a two-terminal resistance of 62 Ω. This has no 
measurable response to hCG. After antibody attachment, the channel resistance increased by 
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16% on exposure to synthetic urine media (Figure 5, inset bottom right). Exposure to the first 
concentration of hCG (3.1 mIU/mL) further increased the channel resistance by 43%. The 
final concentration of hCG (5.62 mIU/mL) increased the channel resistance by 68% relative 
to the value in media. After antibody attachment, urea and cortisol were exposed to the 
antibody-modified graphene channels to measure the sensor selectivity to hCG. A negligible 
response was measured (Figure 5, inset top left). The sensor response (measured resistance) 
to urea and cortisol both vary by less than 20 Ohms which within the experimental error 
margin of the sensor.  This is well below the response measured for hCG, where the measured 
resistance increases by 620 Ohms over the same concentration range. This indicates that there 
is little if any non-specific binding from urea or cortisol and that hCG produces a clearly 
detectable and specific response in the sensor. 
Figure 5 illustrates that the sensor response to hCG is linear and is indicative of repeatable 
behavior in identical graphene sensors.  
 
-Please insert figure 5 here- 
 
3.5. Comparison with ELISA   
ELISA tests are a standard technique for detecting the presence of an antigen within a sample. 
The sandwich ELISA provides high specificity by capturing an antigen with a specific 
antibody immobilized on a solid surface. The antigen becomes immobilized and it can be 
detected by a second antigen specific antibody termed the detection antibody. Detection is 
accomplished by assessing the activity of a conjugated enzyme antibody, specific to the 
detection antibody, via incubation with a substrate to produce data detectable change, usually 
through a color change. The most crucial element of the detection strategy is a highly specific 
antibody-antigen interaction. A sandwich ELISA was developed using the sheep anti-hCG 
antibody as detection antibody to compare the sensitivity of an ELISA to that of the 
amperometric biosensor. The ELISA test was performed under the same conditions 
(temperature, primary antibody concentration) as used for the amperometric sensor.  A 
detection limit of 78 mIU/mL (15.6 ng/mL) was obtained using the ELISA method – this is 
30 times less sensitive than the amperometric graphene sensor. 
 
4. Conclusions 
APTES functionalization, for amine termination of epitaxial graphene in order to attach 
antibody bioreceptors, has been used in the fabrication of an amperometric immunosensor, 
capable of selectively detecting the hormone hCG. This epitaxial graphene biosensor device 
has been demonstrated to be capable of detecting hCG concentrations as low as 0.62 ng/mL, 
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30 times more sensitive than an ELISA test performed under the same conditions. Since the 
attachment mechanism uses non-specific sites of the antibody (i.e. carboxylic groups) to bond 
to the NH2 terminated surface, this method could potentially be adapted to attach other 
antibodies for the detection of other biomarkers. Thus, the APTES-modified graphene 
channel devices offer an easily adaptable, generic sensing platform for detection of a range of 
target biomarkers.  
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Captions for figures 
 
Figure 1. Covalent attachment of 3-aminopropyltriethoxysilane (APTES) to the hydroxyl-
terminated graphene surface. 
 
Figure 2. (a) XPS core level spectrum of the Si2p peak of an epitaxial graphene sample 
(grown on SiC) before functionalization, in black measured data and in red fitted peak 
attributed to SiC (b) XPS core level spectrum of the Si2p peak of an epitaxial graphene sample 
after functionalization, in black measured data, in red fitted peak attributed to SiC and in blue 
fitted peak attributed to the silicon atom of the APTES molecule (c) XPS core level spectrum 
of the C1s peak of a graphene sample before functionalization, in black measured data, in red 
fitted SiC peak and in blue fitted epitaxial graphene peak  (d) XPS core level spectrum of the 
C1s peak of a graphene sample after functionalization, in black measured data, in blue  fitted 
graphene peak, in red fitted SiC peak and in green fitted APTES peak. 
 
Table 1. Description of bonds and atomic abundances calculated from the fitted components 
of the C1s, Si2p and N1s core peaks from XPS measurement before and after functionalization 
with APTES. 
 
Figure 3. Cyclic Voltammograms measurements before (black) and after (red) APTES 
attachment. 
 
Figure 4. Raman spectrum of graphene before (red) and after (black) APTES 
functionalization. 
 
Figure 5. hCG concentration as a function of the resistance across a 100µmx4mm graphene 
channel. Urea and cortisol concentration as a function of the resistance across the channel 
(inset, top left). The I-V characteristics are plotted (inset, bottom right) for the unmodified 
device (black curve), amine terminated graphene surface (red curve), and AB attachment 
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